Samil Pharmaceutical signs MOU to develop innovative products with Yozma Group Korea

Published: 2017-05-24 13:42:14

Updated: 2017-05-24 13:42:14

Samil Pharmaceutical(CEO Seung-Bum Huh) signed a memorandum of understanding for strategic partnership and commercialization of innovative new products related to medicine, health functional food and cosmetic with Yozma Group Korea(Branch Manager Won-Jae Lee).

The Yozma Group, a global venture capital established in Israel in 1993, has made huge contributions for Israel to make overseas invest...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.